Dr. Rogaeva’s graduate degree (1983) and PhD in Biochemistry (1988) were obtained at Moscow State University. For the past 30 years, she has been doing genetic research at the University of Toronto in Tanz Centre for Research in Neurodegenerative Diseases.

In 2001, Dr. Rogaeva obtained the New Pioneer Award from the Ontario government in the Science & Technology category. In 2013, she obtained the Lewy Body Chair position, and was promoted to Full Professor in 2015.

Dr. Rogaeva contributed to 327 peer-reviewed papers (https://pubmed.ncbi.nlm.nih.gov/?term=rogaeva&sort=date) with h-index=100. Most of these papers are focused on the development of effective genetic testing of neurodegenerative diseases (eg, Alzheimer’s Disease, amyotrophic lateral sclerosis and Parkinson’s Disease). For instance, she played a central role in the discovery of several genes associated with the early- and late-onset forms of Alzheimer’s Disease (eg, PSEN1, PSEN2 and SORL1). More recently, Dr. Rogaeva's studies are focused on the link between neurodegenerative disorders and epigenetic events, such as age-related DNA methylation reflecting the biological aging.